» Articles » PMID: 39696586

Obesity and Hyperlipidemia Were Associated with More Severe Synovitis and Structural Abnormalities As Well As Inferior Functional Outcomes in Knee Osteoarthritis: a Retrospective Comparative Study

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2024 Dec 19
PMID 39696586
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Considering that the respective effects of obesity and hyperlipidemia on knee osteoarthritis (OA) have not been fully investigated, the purpose of this study was to determine the relationship of obesity or hyperlipidemia with the synovitis and structural abnormalities of knee OA, and the effect of obesity and hyperlipidemia on functional outcomes of total knee arthroplasty.

Methods: There were 99 OA patients without obesity and hyperlipidemia in Group 1, 100 OA patients only with obesity in Group 2, 98 OA patients only with hyperlipidemia in Group 3, and 97 OA patients with both obesity and hyperlipidemia in Group 4. Semi-quantitative synovial inflammatory markers were measured including effusion-synovitis, size and intensity of infrapatellar fat pad abnormality, and synovial proliferation score. The structural abnormalities of knee OA were evaluated using Whole-Organ Magnetic Resonance Imaging Score (WORMS). Functional outcomes were evaluated before surgery and at 2 years follow-up.

Results: There were significantly higher effusion-synovitis, size and intensity of infrapatellar fat pad abnormality, and synovial proliferation score, as well as higher cartilage, bone marrow edema, meniscus, and total WORMS scores in Group 2, Group 3, and Group 4 (P < 0.05), but with no significant difference between Group 2 and Group 3 (P > 0.05). Group 2, Group 3, Group 4 had significantly worse Western Ontario and McMaster Universities Osteoarthritis Index, Forgotten Joint Score, Oxford Knee Score, Knee Society Score at baseline and 2 years follow-up (P < 0.05), but with no significant difference between Group 2 and Group 3 (P > 0.05). There were significant associations of obesity or hyperlipidemia with all synovial inflammatory markers and cartilage, bone marrow edema, meniscus, and total WORMS scores as well as functional outcomes (P < 0.05).

Conclusions: Obesity and hyperlipidemia were associated with more severe synovitis and structural abnormalities of knee OA, as well as inferior preoperative and postoperative functional outcomes. The negative effects of obesity and hyperlipidemia on knee OA could be mutually enhanced. The findings emphasized the negative effects of obesity and hyperlipidemia on the symptoms and outcomes of knee OA, and highlighted the association of obesity and hyperlipidemia with synovitis.

Citing Articles

Non-linear associations between blood glucose, blood lipids and inflammatory markers and new-onset arthritis in the middle-aged and older population - a cohort study in Europe.

Qiu F, Li J, Legerlotz K Lipids Health Dis. 2025; 24(1):79.

PMID: 40025473 PMC: 11872311. DOI: 10.1186/s12944-025-02495-9.

References
1.
Heilmeier U, Mamoto K, Amano K, Eck B, Tanaka M, Bullen J . Infrapatellar fat pad abnormalities are associated with a higher inflammatory synovial fluid cytokine profile in young adults following ACL tear. Osteoarthritis Cartilage. 2019; 28(1):82-91. PMC: 6935420. DOI: 10.1016/j.joca.2019.09.001. View

2.
Bacon K, LaValley M, Jafarzadeh S, Felson D . Does cartilage loss cause pain in osteoarthritis and if so, how much?. Ann Rheum Dis. 2020; 79(8):1105-1110. PMC: 10406023. DOI: 10.1136/annrheumdis-2020-217363. View

3.
Dawson J, Fitzpatrick R, Murray D, Carr A . Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br. 1998; 80(1):63-9. DOI: 10.1302/0301-620x.80b1.7859. View

4.
Kellgren J, Lawrence J . Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16(4):494-502. PMC: 1006995. DOI: 10.1136/ard.16.4.494. View

5.
Gersing A, Schwaiger B, Nevitt M, Zarnowski J, Joseph G, Feuerriegel G . Weight loss regimen in obese and overweight individuals is associated with reduced cartilage degeneration: 96-month data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2019; 27(6):863-870. PMC: 9115848. DOI: 10.1016/j.joca.2019.01.018. View